However, the small sample size could be masking a significant difference between the two groups, particularly for PLT-bound CD8 T cells and CD3+/CD56+ cells, where several patients display a higher frequency of aggregates at the tumor site compared to the peripheral blood. The gene discussed is NCAM1; the disease is neoplasm.